Among those, PPARα could control the gene expression level of peroxisomal β-oxidation rate limiting enzymes to regulate hepatic lipid and plasma lipoprotein metabolism to avoid excessive lipid accumulation and prevent the progression of NAFLD [34]. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.